P-0240A PHASE II STUDY OF PANITUMUMAB PLUS IRINOTECAN FOR METASTATIC COLORECTAL CANCER PATIENTS WITH WILD KRAS EXON 2, RESISTANT TO FLUOROPYRIMIDINE, OXALIPLATIN AND IRINOTECAN IN JAPANESE. (OGSG1001)
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI